These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2883498)

  • 1. The new genetics: will it pay its way?
    Chapple JC; Dale R; Evans BG
    Lancet; 1987 May; 1(8543):1189-92. PubMed ID: 2883498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs, effects, and savings of screening for cystic fibrosis gene carriers.
    Wildhagen MF; Hilderink HB; Verzijl JG; Verheij JB; Kooij L; Tijmstra T; ten Kate LP; Habbema JD
    J Epidemiol Community Health; 1998 Jul; 52(7):459-67. PubMed ID: 9799881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The resource implications and service outcomes of genetic services in the context of DNA technology.
    Beech R; Rona RJ; Mandalia S
    Health Policy; 1994 Jan; 26(3):171-90. PubMed ID: 10133130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct marketing of cystic fibrosis carrier screening: commercial push or population need?
    Cuckle H; Lilford R; Wilson J; Sehmi I
    J Med Genet; 1995 Sep; 32(9):758. PubMed ID: 8544204
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications of the new genetics for screening for cystic fibrosis.
    Dodge JA
    Lancet; 1988 Sep; 2(8612):672-4. PubMed ID: 2901527
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia.
    Tsai MC; Cheng CN; Wang RJ; Chen KT; Kuo MC; Lin SJ
    J Formos Med Assoc; 2015 Aug; 114(8):722-8. PubMed ID: 23932837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
    Pollitt RJ; Green A; McCabe CJ; Booth A; Cooper NJ; Leonard JV; Nicholl J; Nicholson P; Tunaley JR; Virdi NK
    Health Technol Assess; 1997; 1(7):i-iv, 1-202. PubMed ID: 9483160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GIG response to the UK Clinical Genetics Society report "The genetic testing of children".
    Dalby S
    J Med Genet; 1995 Jun; 32(6):490-1. PubMed ID: 7666405
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the Human Genome Initiative on women's rights and reproductive decisions.
    Charo RA
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):148-59. PubMed ID: 11653014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic screening for reproductive planning: methodological and conceptual issues in policy analysis.
    Asch DA; Hershey JC; Pauly MV; Patton JP; Jedrziewski MK; Mennuti MT
    Am J Public Health; 1996 May; 86(5):684-90. PubMed ID: 8629720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of DNA diagnosis for four monogenic diseases.
    van der Riet AA; van Hout BA; Rutten FF
    J Med Genet; 1997 Sep; 34(9):741-5. PubMed ID: 9321760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics in clinical practice: evolution of a DNA diagnostic service.
    Meredith AL; Upadhyaya M; Harper PS
    BMJ; 1988 Oct; 297(6652):843-6. PubMed ID: 2972330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.